Frustrated by the rising cost of prescription drugs, California health advocates hope sunlight and a dose of shame will discourage drugmakers from raising their prices too quickly or introducing new medications at prices ...
Jul 10, 2016
0
6
Americans spent $30.2 billion—$28.3 billion for adults and $1.9 billion for children—out-of-pocket on complementary health approaches, according to a nationwide survey. These approaches include a group of diverse medical ...
Jun 22, 2016
0
81
(HealthDay)—Democratic presidential candidate Bernie Sanders is promoting his version of single-payer health care, although the actual impact of such a system is unclear, according to a report published in Medical Economics.
Jun 17, 2016
0
2
The economic crisis of 2008-10, and the rise in unemployment that accompanied it, was associated with more than 260,000 excess cancer-related deaths—including many considered treatable—within the Organization for Economic ...
May 25, 2016
1
4
They've brought hope to millions, drugs so revolutionary that they can cure hepatitis C and so expensive that neither patients nor public health services can afford them—an issue to be raised at this week's G7.
May 25, 2016
0
17
It is known that syphilis rates have varied much between different countries and populations over the past 100 years. A study published in PLOS Neglected Tropical Diseases collates a history of the disease and finds that ...
May 11, 2016
0
6
Offering a health care services price transparency tool to employees at 2 large companies was not associated with lower outpatient spending, according to a study appearing in the May 3 issue of JAMA.
May 3, 2016
0
6
One key goal of the Affordable Care Act (ACA) was to lower health care costs by giving consumers more choice over their insurer.
May 2, 2016
0
5
Global inequities in health spending are expected to persist and intensify over the next 25 years, according to a new study that estimates total health financing in countries around the world.
Apr 14, 2016
1
1
U.S. spending on prescription drugs rose 8.5 percent last year, slightly less than in 2014, driven mainly by growing use of ultra-expensive new drugs and price hikes on other medicines.
Apr 14, 2016
0
3
